前药
化学
二肽
肽
亲核细胞
组合化学
药品
立体化学
药理学
生物化学
催化作用
医学
作者
Arnab De,Richard D. DiMarchi
出处
期刊:Biopolymers
[Wiley]
日期:2010-01-01
卷期号:94 (4): 448-456
被引量:14
摘要
Abstract Peptides represent a rich natural source of potential medicines with one notable pharmaceutical limitation being their relatively short duration of action. A particularly good example of this phenomenon is glucagon‐like peptide 1 (GLP), a hormone of appreciable interest for the treatment of type II diabetes. In the native form, GLP demonstrates an extremely short half‐life in plasma and a relatively narrow therapeutic index with gastrointestinal adverse pharmacology. We envisioned a prodrug of GLP as a means to extend the duration of action and broaden the therapeutic index of this peptide hormone. We designed, synthesized, and characterized ester‐based prodrugs of GLP that differentially convert to the parent drug under physiological conditions driven by their inherent chemical instability. In a set of dipeptide extended GLP‐analogs we explored the rate of diketopiperazine (DKP) and diketomorpholine (DMP) formation, and the release of the active peptide. The rate of cleavage was observed to be a function of the conformation of the dipeptide promoiety and the strength of the cyclization nucleophile. Through the careful selection of chemical functionality, a set of GLP ester prodrugs of variable half‐lives has been identified. © 2010 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 94: 448–456, 2010.
科研通智能强力驱动
Strongly Powered by AbleSci AI